SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001410939-20-000026
Filing Date
2020-06-10
Accepted
2020-06-10 09:08:42
Documents
14
Period of Report
2020-06-09
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K a8-kx2020agm.htm   iXBRL 8-K 55173
  Complete submission text file 0001410939-20-000026.txt   201373

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT opht-20200609.xsd EX-101.SCH 4454
3 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT opht-20200609_cal.xml EX-101.CAL 627
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT opht-20200609_def.xml EX-101.DEF 1477
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT opht-20200609_lab.xml EX-101.LAB 27268
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT opht-20200609_pre.xml EX-101.PRE 14117
14 EXTRACTED XBRL INSTANCE DOCUMENT a8-kx2020agm_htm.xml XML 4814
Mailing Address ONE PENN PLAZA 35TH FLOOR NEW YORK NY 10119
Business Address ONE PENN PLAZA 35TH FLOOR NEW YORK NY 10119 212-845-8200
IVERIC bio, Inc. (Filer) CIK: 0001410939 (see all company filings)

IRS No.: 208185347 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36080 | Film No.: 20953629
SIC: 2834 Pharmaceutical Preparations